ESMO recommendations for the application of haematopoietic growth factors (hGFs).
D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use; D016026:Bone Marrow Transplantation; D005334:Fever / Q000150:complications / Q000188:drug therapy* / Q000209:etiology; D006084:Graft Rejection; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000494:pharmacology / Q000627:therapeutic use*; D019650:Hematopoietic Stem Cell Mobilization; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D007938:Leukemia / Q000188:drug therapy; D009369:Neoplasms / Q000188:drug therapy; D009503:Neutropenia / Q000150:complications / Q000188:drug therapy* / Q000209:etiology; D017410:Practice Guidelines as Topic; D018570:Risk Assessment
D000970:Antineoplastic Agents; D016178:Granulocyte-Macrophage Colony-Stimulating Factor